Articles On Telix Pharmaceuticals (ASX:TLX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Guess which ASX 200 healthcare stock is tumbling despite announcing US$230m acquisition
Telix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday morning. At the time of writing, the ASX 200 healthcare stock is down 3.5% to $19.57 Why is this ASX 200 healthcare stock falling? Investors have been selling the company's s... |
Motley Fool | TLX | 1 year ago |
|
ASX 200 Decline Expected Amid Key Updates: RBA Meeting, Inflation Data, and Corporate Developments
The ASX 200 is forecasted to experience a downturn, with futures down 0.8% to 8190 points, following last week's record highs. A range of important economic events and corporate updates are expected to influence market movements. The Aus... |
Kalkine Media | TLX | 1 year ago |
|
Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswi... |
FNArena | TLX | 1 year ago |
|
Telix increases North American footprint with RLS acquisition
Melbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) is set to expand its manufacturing and distribution footprint in North America with the acquisition of RLS Inc – the only US radiopharmacy network which is Joint Commission-accredited.... |
themarketonline.com.au | TLX | 1 year ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) ended the trading week on a high this Friday. Literally so, with the index once again resetting its intraday trading re... |
Motley Fool | TLX | 1 year ago |
|
ASX up 0.45% near noon: IT is best performing sector
Aus shares have reached a record high, while Myer highlights challenging market conditions. Regis Healthcare and Kelsian have secured significant contracts, and Namoi Cotton has endorsed Olam Agri's acquisition bid. The Australian dollar ha... |
ShareCafe | TLX | 1 year ago |
|
Here are the top 10 ASX 200 shares today
It was a bouncy but overall positive day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. By the time trading closed, the ASX 200 had climbed by ano... |
Motley Fool | TLX | 1 year ago |
|
Here are the top 10 ASX 200 shares today
It ended up being quite a wonderful day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday. The ASX 200 managed to add 0.24% to its value and closed up at 8... |
Motley Fool | TLX | 1 year ago |
|
ASX up 0.23% near noon: A-REIT is best performing sector
At 11:40am, the S&P/ASX 200 is 0.23 per cent higher at 8,140.50. This comes amid expectations of a significant 50 basis point interest rate cut by the Federal Reserve later this week, with JPMorgan predicting the move and CME Futures da... |
ShareCafe | TLX | 1 year ago |
|
Australian sharemarket hits record high amid US stock surge
The Australian sharemarket briefly touched a new record high on Monday, mirroring a surge in US stocks. Banks and gold stocks led the gains, while energy and health sectors lagged.At the closing bell, the S&P/ASX 200 was 0.27 per cent h... |
ShareCafe | TLX | 1 year ago |
|
ASX up 0.37% near noon amid Wall Street rally
At 11:35am, the S&P/ASX 200 is 0.37 per cent higher at 8,130.20, buoyed by a rally on Wall Street driven by gains in tech and gold stocks. US stocks surged on Friday amid expectations that the US Federal Reserve will lower interest rate... |
ShareCafe | TLX | 1 year ago |
|
Alive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the job
Alive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday. Prescient Therapeutics chief Steve Yatomi-Clarke resigns to hea... |
Stockhead | TLX | 1 year ago |
|
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
Two ASX 200 Shares to Watch Today: Mineral Resources Ltd (ASX: MIN) and Telix Pharmaceuticals Ltd (ASX: TLX)
Investors are keeping a close eye on several S&P/ASX 200 Index (ASX: XJO) shares, with two particular stocks standing out for their potential to outperform. These two companies represent different sectors—one in mining and the other in... |
Kalkine Media | TLX | 1 year ago |
|
2 compelling ASX 200 shares to buy today
Below, we look at two compelling S&P/ASX 200 Index (ASX: XJO) shares you may wish to consider adding to your portfolio. One stock has been under intense selling pressure in 2024 while the other has seen its share price rocket. And David... |
Motley Fool | TLX | 1 year ago |
|
FNArena Corporate Results Monitor – 06-09-2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AIS)) – Aeris... |
FNArena | TLX | 1 year ago |
|
ASX up 0.17% near noon: Commodities mixed
Australian shares opened higher, buoyed by a rise in tech stocks, particularly Tesla and Amazon, which lifted the Nasdaq amid mixed performance on Wall Street. At 11:35am, the S&P/ASX 200 is 0.17 per cent higher at 7,995.60, with four o... |
ShareCafe | TLX | 1 year ago |
|
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
Alive and Kicking: Noxopharm has difficult brain cancer in its sights
Noxopharm says two novel drug candidates significantly reduced glioblastoma (brain cancer) cell growth in preclinical models. Percheron Therapeutics announces “very encouraging” new data for its epilepsy program Cyclopharm is off to a soli... |
Stockhead | TLX | 1 year ago |
|
ASX down 0.3% near noon contrasting with S&P500
In the first session of the week, the Australian sharemarket is experiencing a decline, primarily driven by weakness in mining and communications stocks. By midday, the S&P/ASX 200 index is down 0.3 per cent, hovering near 8067 points.... |
ShareCafe | TLX | 1 year ago |
|
Dr Boreham’s Crucible: Diverse ASX biotech gun Telix brushes off suggestions its peaked
Telix Pharmaceuticals (ASX:TLX) CEO and co-founder Dr Chris Behrenbruch is blunt about why some fund managers believe the ASX market darling is entering ‘overvalued’ territory. “The fundies probably hate [us] because they didn’t get their a... |
Stockhead | TLX | 1 year ago |
|
The Overnight Report: No Nvidia Fireworks
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Looks like the local market is set for yet again a weaker opening on Thursday. Wor... |
FNArena | TLX | 1 year ago |
|
ASX closes flat as Woolworths reports results
The Australian share market closed flat on Wednesday, with consumer staples offsetting losses in commodity stocks. Woolworths' strong earnings boosted the consumer staples sector, while lower iron ore and uranium prices weighed on mining an... |
ShareCafe | TLX | 1 year ago |
|
Telix wins fast track status from US FDA for new brain cancer PET scan imaging agent
Telix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA within the approvals chain for the assessment of Telix’s PET-scan brain cancer imaging agent Pixclara. The company is focusing particularly on... |
themarketonline.com.au | TLX | 1 year ago |
|
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 28, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
The Overnight Report: Waiting For Nvidia
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7996.00 – 29.00 – 0.36% S&P ASX 200 8071.20... |
FNArena | TLX | 1 year ago |
|
Telix shares extend gains amid 'evolving' leadership changes
Telix Pharmaceuticals Ltd (ASX: TLX) shares are drifting higher on Tuesday, extending gains to 98% for the year to date. Shares in the biopharmaceutical company are swapping hands less than 1% higher at $19.90 apiece at the time of publ... |
Motley Fool | TLX | 1 year ago |
|
Telix Announces Reorganisation to Deliver on Strategic Priorities
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
The Overnight Report: BHP, Coles & Woodside
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8041.00 + 4.00 0.05% S&P ASX 200 8084.50 + 6... |
FNArena | TLX | 1 year ago |
|
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight.... |
Stockhead | TLX | 1 year ago |
|
Why Fund Managers Are Growing Discontented with These 10 ASX Stars
For chief executives and institutional investors, the critical phase of earnings season begins after the analyst calls, media interviews, and the presentation of results have concluded. Investor roadshows offer a unique opportunity for fund... |
Kalkine Media | TLX | 1 year ago |
|
Australian Shares Set to End 10-Day Winning Streak
Australian shares are poised to end a 10-day winning streak on Friday, with the market opening down 0.2 percent at 8008 points. This decline follows a negative session on Wall Street, where the Nasdaq (NASDAQ:IXIC) experienced a drop of 1.7... |
Kalkine Media | TLX | 1 year ago |
|
Telix share price sinks 9% despite stellar half-year growth
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move on Friday morning. At the time of writing, the ASX 200 healthcare stock is down 9% to $18.04. This follows the release of its half-year results after the market close yeste... |
Motley Fool | TLX | 1 year ago |
|
ASX 200 Sees Modest Gains, Market Eyes Friday Session
On Thursday, the S&P/ASX 200 Index (ASX: XJO) recorded a modest gain, rising 0.2% to close at 8,027 points. As the market gears up for Friday’s session, several factors could influence the day's performance: ASX 200 Set for a Slight Di... |
Kalkine Media | TLX | 1 year ago |
|
5 things to watch on the ASX 200 on Friday
On Thursday, the S&P/ASX 200 Index (ASX: XJO) had another decent session and recorded a small gain. The benchmark index rose 0.2% to 8,027 points. Will the market be able to build on this on Friday and end the week on a high? Here are... |
Motley Fool | TLX | 1 year ago |
|
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
ASX down 0.07% near noon: Consumer Staples is worst performing sector
At 11:40am, the S&P/ASX 200 is 0.07 per cent lower at 7,965.9, the Australian share market opened lower, influenced by a decline in consumer staples stocks. Investors reacted to a wave of company earnings released on Monday. A2 Milk exp... |
ShareCafe | TLX | 1 year ago |
|
ASX up 1.39% near noon: Investors respond to US retail sales data
At 11:30am, the S&P/ASX 200 is 1.39 per cent higher at 7,974.5, driven by optimism about potential interest rate cuts and robust economic data. Investors responded positively to strong US retail sales and positive GDP figures from Japan... |
ShareCafe | TLX | 1 year ago |
|
Rudi’s View: Model Portfolios, Best Ideas & Conviction Calls
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor Morningstar's Best Equity Ideas for A... |
FNArena | TLX | 1 year ago |
|
Why are ASX healthcare shares dragging on the ASX 200 today?
It's been a bouncy, yet positive session for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has added a decent 0.17%, putting the index at around 7,830 points. But it wo... |
Motley Fool | TLX | 1 year ago |
|
Which ASX 200 market sector has been the best performer over 10 years?
The S&P/ASX 200 Index (ASX: XJO) comprises 11 market sectors, and the outperformer over the past decade may surprise you. It's not the flashy tech sector, nor the sectors home to the mega-miners or the Big Four bank shares. I... |
Motley Fool | TLX | 1 year ago |
|
ASX up 0.2% near noon: RBA says no rate cuts this year
At 11:40am, the S&P/ASX 200 is 0.2 per cent higher at 7,695.60. Michele Bullock's calm and steady demeanor as a central banker is essential to mitigating market panic. She effectively reassured the market with the RBA's statement and he... |
ShareCafe | TLX | 1 year ago |
|
ASX up 0.2% near noon: Investors await for further economic indicators
The Australian sharemarket rebounded today after heavy selling yesterday. At noon, the S&P/ASX 200 is 0.2 per cent higher at 7,665. This rebound comes amid a broader global market upheaval triggered by growing concerns over a potential... |
ShareCafe | TLX | 1 year ago |
|
The Overnight Report: Fed Rate Cuts Are Coming
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8084.00 + 23.00 0.29% S&P ASX 200 8092.30 +... |
FNArena | TLX | 1 year ago |
|
ASX surges 1.8% driven by low inflation figures
The Australian sharemarket surged 1.8% on Wednesday, driven by unexpectedly low inflation figures, quashing expectations of a rate hike. All sectors experienced gains, led by consumer discretionary and materials stocks. Consumer confidence... |
ShareCafe | TLX | 1 year ago |
|
Up 86% in 2024, why is the Telix Pharmaceuticals share price tumbling today?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed yesterday trading for $19.32. In early afternoon trade on Wednesday, shares a... |
Motley Fool | TLX | 1 year ago |
|
Why Brainchip, Gold Road, Mesoblast, and Telix shares are tumbling today
The S&P/ASX 200 Index (ASX: XJO) is on track to record a strong gain on Wednesday. At the time of writing, the benchmark index is up 1.2% to 8,050.1 points. Four ASX shares that have failed to follow the market higher today are listed... |
Motley Fool | TLX | 1 year ago |
|
ASX up 1.1% near noon: CPI increases to 3.8% in June quarter
Australian annual inflation increased to 3.8% in the June quarter, aligning with market expectations. While quarterly inflation remained steady at 1%, core inflation eased slightly. This data will significantly influence the Reserve Bank of... |
ShareCafe | TLX | 1 year ago |
|
2 ASX healthcare shares making splashes in the US
ASX healthcare shares are often touted here on the Australian share market. We are home to some of the most innovative players in the healthcare domain. But there's also a handful of companies that are growing their business over in the... |
Motley Fool | TLX | 1 year ago |
|
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Nova Minerals (ASX:NVA) shares dipped nearly -3% in Friday morning trades after announcing it was closing the pre-listing IPO process for its new NASDAQ digs. The company is listing on the tech heavy stock market at a value of only US$3.... |
themarketonline.com.au | TLX | 1 year ago |